Critical Process Parameters in Primary Cell Manufacturing: Why & How They Matter for MSCs or Human… April 13, 2026 Biomanufacturing, Quality & Regulatory
MSC-EV Characterization Q&A: CD73, Downstream Processing, & Scalable Manufacturing Answered April 01, 2026 Bioprocessing, Exosomes / Extracellular Vesicles
Balancing the Scale from the Cellular Bank August 06, 2025 Biomanufacturing, Bioprocessing, Cell Therapy
When Data Blooms: Insights into MSC-EV Bioprocessing May 19, 2025 Bioprocessing, Exosomes / Extracellular Vesicles
To 10X & Beyond, AgentV™-DSP Arrives Ready to Rock February 27, 2025 Biomanufacturing, Bioprocessing, Exosomes / Extracellular Vesicles
Analytics: A Referee for the Tug-of-War Between MSC-EVs’ Nature & Nurture December 20, 2024 Bioprocessing, Exosomes / Extracellular Vesicles
Cytiva & RoosterBio’s Collaboration Yields Breakthroughs to Make Exosome Manufacture Easier from… October 29, 2024 Biomanufacturing, Exosomes / Extracellular Vesicles
AgentV’s Virtues at the Vanguard of Extracellular Vesicles July 31, 2024 BioEconomy, Biomanufacturing, Bioprocessing, Exosomes / Extracellular Vesicles
